TMCnet News
Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Vaccine Development Program and Files Trademark Application for The Complete Vaccine™
[December 31, 2020]
Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Vaccine Development Program and Files Trademark Application for The Complete Vaccine™
The trademark application can be found at USPTO.gov by searching âComplete Vaccineâ in the Trademark Electronic Search System (TESS)
Ii-Key-SARS-CoV-2 vaccine enters GMP production for clinical supply
Ii-Key epitopes selected that elicit both CD4+ T Helper cell (Th1) and CD8+ responses that are necessary for long-term immune memory
Ii-Key epitopes elicited no Th2 T cell responses that have been linked to antibody dependent enhancement of disease and cytokine storm
Comirnaty (BNT162b2) Vaccine precisionvaccinations.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from precisionvaccinations.com Daily Mail and Mail on Sunday newspapers.
BNT162 COVID-19 Vaccine precisionvaccinations.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from precisionvaccinations.com Daily Mail and Mail on Sunday newspapers.
NAIROBI, Dec. 10 (Xinhua) African governments should embark on proactive engagement with local communities to boost uptake of COVID-19 vaccine once they are deployed in the continent, a senior World Health Organization (WHO) official said on Thursday.